What now? A conventional vaccine is made from killed

[zakiyatasnim]

What now? Last year, Tesla shipped half a million cars, and a total of 3.1 million electric vehicles of all brands were sold. This is 43% more than in 2019. The largest market is China, where half of all electric cars are sold.

What's next? Manufacturers are phasing out the internal combustion engine and moving to electric vehicles. By 2030, one in four cars will be electric.



Development of a vaccine based on messenger RNA
How it all began. Messenger RNA (mRNA) is the pure genetic material of a virus that is created artificially. The first manufacturer of an RNA-based vaccine is Moderna. Data about the virus is entered into software, analyzed, and then mRNA is created. The company's CEO, Stefan Bansel, said that the development was based on the software that Tesla uses to manage orders.

or weakened viruses. To create one based on mRNA, it is enough to decipher the virus genome - and the vaccine can be developed and put into production in a few days. On January 11, 2020, Chinese scientists published the genetic sequence of SARS-CoV-2 (COVID-19). 48 hours later, Moderna had a development plan ready. 42 days later, the first batch of the vaccine was released, and in early March, the company began testing it on humans. On December 8, 2020, the use was approved in the United States. For comparison: after the SARS outbreak in 2002-2003, it took 20 months from development to testing of the vaccine. The second mRNA-based vaccine was developed by Pfizer.

What's next? The technology opens up revolutionary opportunities lithuania number data in drug development. However, other pharmaceutical companies are in no hurry to implement it in their own. The reason is side effects. Because of them, pharmaceutical giants are not yet ready to use this technology.



Blockchain — something we couldn't predict
How it all began. In 2008, Satoshi Nakamoto proposed a way to verify the authenticity of all transactions without the involvement of a third party. In 2013, 19-year-old Vitalik Buterin was studying computer science at the University of Waterloo in Canada and writing articles for Bitcoin Magazine. He realized that information about any event could be recorded in a blockchain. In late 2013, he described Ethereum in a White Paper as a cryptocurrency and a platform with a common scripting language for developing applications.

What's up. To ensure traceability and transparency of coronavirus vaccines, IBM is offering a distribution network based on IBM Blockchain. The corporation offers manufacturers the ability to monitor side effects and improve the efficiency of vaccine recall management. Blockchain will help distributors gain enhanced capabilities to respond to supply chain disruptions. It will become easier for pharmacists to optimize inventory management.

What's next? Blockchain will evolve, eliminating unnecessary and expensive intermediaries.